Riskpilot← Back to searchSign inGet full accessLINDESNES LEGEHUS AS
ASActiveOrg 982824877Rådhusveien, 4520 LindesnesRental and operating of own or leased real estate · NACE 6820Est. 20010 employees
Revenue 2025
NOK 931K
+4% vs 2024
EBITDA margin
83.0%
0% vs 2024
Equity ratio
85.1%
Financial strength
Net profit 2025
NOK 358K
+7% vs 2024
| Revenue | NOK 931K | +4% |
| EBITDA | NOK 772K | +0% |
| Net profit | NOK 358K | +7% |
| Total assets | NOK 2,2M | -8% |
| Equity | NOK 1,9M | +23% |
| Employees | 0 | — |
Legal name
LINDESNES LEGEHUS AS
Org number
982824877
Legal form
Aksjeselskap
NACE code
6820 · Rental and operating of own or leased real estate
Founded
17. januar 2001
Share capital
NOK 400 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Drift og utleie av bygning samt alt det som dermed står i forbindelse, herunder gjennom aksjetegning eller på annen måte delta i andre selskaper.
Address
Rådhusveien, 4520 Lindesnes
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 739 | 764 | 854 | 894 | 931 |
| Staff expenses | −0 | −0 | −0 | −11 | −0 |
| EBITDA | 562 | 737 | 761 | 776 | 772 |
| Depreciation & amort. | −243 | −238 | −238 | −244 | −247 |
| EBIT | 319 | 499 | 523 | 532 | 526 |
| Net financials | −50 | −72 | −90 | −67 | −27 |
| Profit before tax | 269 | 427 | 432 | 465 | 498 |
| Tax | 85 | 120 | 123 | 131 | 141 |
| Net profit | 185 | 306 | 309 | 334 | 358 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 222 | 2 965 | 2 696 | 2 421 | 2 223 |
| Equity | 585 | 892 | 1 201 | 1 535 | 1 892 |
| Long-term debt | 2 550 | 1 950 | 1 350 | 750 | 150 |
| Short-term debt | 87 | 123 | 146 | 136 | 181 |
| Total debt | 2 637 | 2 073 | 1 496 | 886 | 331 |
EBITDA margin
83.0%
This company
15.8%
Market median
+425% vs market
20212025
Equity ratio
85.1%
This company
38.2%
Market median
+123% vs market
20212025
Return on equity
18.9%
This company
18.4%
Market median
+3% vs market
20212025
Net profit margin
38.4%
This company
8.1%
Market median
+374% vs market
20212025
Asset turnover
0.42×
This company
1.12×
Market median
-63% vs market
20212025
Debt / equity
0.17×
This company
0.62×
Market median
+73% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 25% | 25% | 2024 | |
| Company | 25% | 25% | 2024 | |
| Company | 25% | 25% | 2024 | |
| Company | 25% | 25% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Neseveien Invest As
LINDESNES LEGEHUS AS Board members of LINDESNES LEGEHUS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Heidi Syvertsen | Chairman | 0 companies |
| Tørres Lohne | Board of Directors | 0 companies |
| David Andersen | Board of Directors | 0 companies |
| Halfdan Corneliussen | Board of Directors | 0 companies |